1. Home
  2. PLBC vs SCLX Comparison

PLBC vs SCLX Comparison

Compare PLBC & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plumas Bancorp

PLBC

Plumas Bancorp

N/A

Current Price

$62.75

Market Cap

426.2M

Sector

Finance

ML Signal

N/A

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$4.90

Market Cap

35.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLBC
SCLX
Founded
1980
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
426.2M
35.2M
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
PLBC
SCLX
Price
$62.75
$4.90
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$57.67
N/A
AVG Volume (30 Days)
34.8K
36.4K
Earning Date
04-15-2026
04-10-2026
Dividend Yield
2.60%
N/A
EPS Growth
N/A
N/A
EPS
2.79
N/A
Revenue
N/A
$30,253,000.00
Revenue This Year
$25.59
$122.52
Revenue Next Year
$5.15
$186.30
P/E Ratio
$22.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.89
$4.20
52 Week High
$64.00
$34.27

Technical Indicators

Market Signals
Indicator
PLBC
SCLX
Relative Strength Index (RSI) 58.13 27.24
Support Level $60.00 $4.20
Resistance Level $63.74 $7.77
Average True Range (ATR) 1.16 0.30
MACD 0.04 0.01
Stochastic Oscillator 85.39 5.93

Price Performance

Historical Comparison
PLBC
SCLX

About PLBC Plumas Bancorp

Plumas Bancorp provides banking products and services in Northeastern California and Northwestern Nevada, offering a range of deposit products for commercial and retail customers, including checking, savings, money market accounts, time deposits, retirement accounts, and sweep accounts for businesses and public entities, along with digital banking services such as mobile and internet banking, remote deposit, and electronic funds transfers, as well as other customary banking services. Its loan portfolio comprises commercial real estate, commercial and industrial, consumer, agricultural, residential real estate, and construction and land development loans, and the company generates its revenue from loans and investment securities, with additional income from service fees.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: